The intersection of artificial intelligence and pharmaceutical research has long been promised as the "holy grail" of...
Treatment Innovations
In a landmark development for the medical imaging sector, California-based Sirona Medical has successfully closed a $40...
In a significant move to modernize its oversight of the orphan drug sector, the U.S. Food and...
The intersection of artificial intelligence and pharmaceutical development has long been framed as a “gold rush,” characterized...
In a significant move that underscores the burgeoning intersection of artificial intelligence and clinical diagnostics, San Francisco-based...
On October 14, 2026, the U.S. Food and Drug Administration (FDA) unveiled a sweeping strategic initiative dubbed...
The marriage of artificial intelligence and drug discovery has long been touted as the "next frontier" of...
In a landmark move for the health-tech sector, San Francisco-based Sirona Medical has announced the successful closure...
In a landmark shift for the biopharmaceutical industry, the U.S. Food and Drug Administration (FDA) has unveiled...
The marriage of artificial intelligence and pharmaceutical research has long been promised as a panacea for the...
